Loading...
XNASLFMDP
Market cap220mUSD
Dec 24, Last price  
22.05USD
1D
-0.23%
1Q
0.23%
Name

LifeMD Inc

Chart & Performance

D1W1MN
XNAS:LFMDP chart

Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
IPO date
Jul 11, 2001
Employees
199
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
152,547
28.15%
119,034
28.16%
92,876
149.04%
Cost of revenue
153,107
146,968
140,886
Unusual Expense (Income)
NOPBT
(560)
(27,935)
(48,010)
NOPBT Margin
Operating Taxes
428
361
8
Tax Rate
NOPAT
(988)
(28,296)
(48,018)
Net income
(20,596)
-54.25%
(45,021)
-26.59%
(61,324)
1.32%
Dividends
(3,106)
(3,106)
(871)
Dividend yield
1.11%
5.17%
0.83%
Proceeds from repurchase of equity
16,203
86,447
BB yield
-5.76%
-82.71%
Debt
Debt current
1,534
3,553
671
Long-term debt
18,679
1,904
2,965
Deferred revenue
Other long-term liabilities
131
1,023
100
Net debt
(12,934)
1,499
(37,693)
Cash flow
Cash from operating activities
8,820
(22,935)
(33,085)
CAPEX
(204)
(12,893)
(3,402)
Cash from investing activities
(8,733)
(13,906)
(3,402)
Cash from financing activities
29,101
(528)
68,637
FCF
(17,013)
(11,355)
(51,194)
Balance
Cash
33,147
3,959
41,328
Long term investments
Excess cash
25,519
36,684
Stockholders' equity
(211,821)
(186,157)
(138,535)
Invested Capital
237,054
181,501
164,303
ROIC
ROCE
599.98%
EV
Common stock shares outstanding
33,905
30,976
27,008
Price
8.29
327.32%
1.94
-49.87%
3.87
-40.74%
Market cap
281,074
367.72%
60,094
-42.50%
104,521
12.13%
EV
270,200
65,683
69,907
EBITDA
6,041
(24,165)
(47,141)
EV/EBITDA
44.73
Interest
2,597
1,276
3,020
Interest/NOPBT